|View printer-friendly version|
|May 20, 2002 4:14 p.m.|
|Teva Announces Tentative FDA Approval for Pravastatin Tablets|
Jerusalem, Israel, May 20, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has granted tentative approval for the company's ANDA for Pravastatin Sodium Tablets, 10 mg, 20 mg and 40 mg. The compound is covered by a patent that expires in 2005.